Amrutanjan Health Care Limited (IN:AMRUTANJAN)
:AMRUTANJAN
AMRUTANJAN Stock Chart & Stats
₹671.50
-₹1.00(-0.14%)
At close: 4:00 PM EST
₹671.50
-₹1.00(-0.14%)
Day’s Range― - ―
52-Week Range₹490.00 - ₹789.95
Previous CloseN/A
Volume4.33K
Average Volume (3M)587.00
Market Cap
₹14.88B
Enterprise Value₹14.73B
Total Cash (Recent Filing)₹2.07B
Total Debt (Recent Filing)₹19.32M
Price to Earnings (P/E)24.8
Beta0.95
Next Earnings
May 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.68%
Share Statistics
EPS (TTM)6.73
Shares Outstanding29,230,630
10 Day Avg. Volume607
30 Day Avg. Volume587
Financial Highlights & Ratios
PEG Ratio2.73
Price to Book (P/B)5.70
Price to Sales (P/S)4.13
P/FCF Ratio121.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Balance SheetLow leverage and substantial cash reserves give the company durable financial flexibility. This supports continued investment in distribution and marketing, cushions against demand shocks, and reduces refinancing risk — important for multi-quarter stability and optionality in strategic initiatives.
Consistent Revenue GrowthA roughly 10% revenue growth trend reflects persistent consumer demand and successful market penetration of core OTC products. Predictable top-line expansion supports longer-term planning, margin retention, and reinvestment in brand and distribution over the next several quarters.
Healthy Profitability And Cash ConversionSustained gross and net margins along with efficient conversion of earnings to operating cash flow underpin internal funding capacity. This strengthens ability to fund working capital, maintain promotions, and support shareholder returns without heavy reliance on external financing over the medium term.
Bears Say
Inconsistent Free Cash FlowVolatile free cash flow growth reduces predictability of available cash for dividends, buybacks, or incremental capex. Over multiple quarters this can constrain strategic investments and force reliance on reserves or external funding when cash generation underperforms expectations.
Margin VolatilityVariability in operating margins signals sensitivity to input costs or inconsistent operating leverage. If sustained, margin swings can erode profitability during cost inflation periods and weaken the company’s ability to reinvest or sustain payouts without price increases that may hurt volume.
Product Concentration RiskHeavy reliance on a single product category and brand narrows revenue diversification. This exposes the business to category-specific demand shifts, intensified competition, or regulatory changes, limiting resilience and upside if the core market faces structural headwinds.
Amrutanjan Health Care Limited News
AMRUTANJAN FAQ
What was Amrutanjan Health Care Limited’s price range in the past 12 months?
Amrutanjan Health Care Limited lowest stock price was ₹490.00 and its highest was ₹789.95 in the past 12 months.
What is Amrutanjan Health Care Limited’s market cap?
Amrutanjan Health Care Limited’s market cap is ₹14.88B.
When is Amrutanjan Health Care Limited’s upcoming earnings report date?
Amrutanjan Health Care Limited’s upcoming earnings report date is May 21, 2026 which is in 45 days.
How were Amrutanjan Health Care Limited’s earnings last quarter?
Amrutanjan Health Care Limited released its earnings results on Feb 03, 2026. The company reported ₹6.731 earnings per share for the quarter, beating the consensus estimate of N/A by ₹6.731.
Is Amrutanjan Health Care Limited overvalued?
According to Wall Street analysts Amrutanjan Health Care Limited’s price is currently Overvalued.
Does Amrutanjan Health Care Limited pay dividends?
Amrutanjan Health Care Limited pays a Quarterly dividend of ₹1 which represents an annual dividend yield of 0.68%. See more information on Amrutanjan Health Care Limited dividends here
What is Amrutanjan Health Care Limited’s EPS estimate?
Amrutanjan Health Care Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Amrutanjan Health Care Limited have?
Amrutanjan Health Care Limited has 29,230,630 shares outstanding.
What happened to Amrutanjan Health Care Limited’s price movement after its last earnings report?
Amrutanjan Health Care Limited reported an EPS of ₹6.731 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.052%.
Which hedge fund is a major shareholder of Amrutanjan Health Care Limited?
Currently, no hedge funds are holding shares in IN:AMRUTANJAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Amrutanjan Health Care Limited
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms, non-alcoholic beverages, and sanitary napkins. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons and lotions, body pain gels, and joint muscle sprays, as well as diclofenac, a non-steroidal anti-inflammatory drug. The company offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints. It also provides sanitary napkins for women. In addition, the company offers corn caps; hand sanitizers; and juice drinks under the Fruitnik and Fruitnik Electro+ brand names, as well as operates a pain management center. It exports its products to the Middle East, Africa, South East Asia, and internationally. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.
Technical Analysis
Indoco Remedies Limited
―
Krsnaa Diagnostics Limited
―
TTK Healthcare Limited
―
Zota Health Care Ltd.
―